Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline vs Ertapenem in Complicated Urinary Tract Infections (IGNITE3)
NCT03032510Phase 3Completed
- Sponsor
- Tetraphase Therapeutics
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 12
01
Overview
Phase 3, randomised, double-blind trial of eravacycline in complicated urinary tract infection (cUTI) (2 arms), sponsored by Tetraphase Therapeutics. Primary endpoint: Proportion of Participants in the Micro-ITT Population Demonstrating Clinical Cure and Microbiologic Success. Started Jan 2017; status: completed.
02
Drugs
eravacycline
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT03032510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03032510.